“MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.
article
OA: closed
CC0
⤵ 96 in-corpus citations
AI-generated summary
This study found that a long-acting GnRH agonist significantly suppressed estrogen secretion in women with endometriosis, mimicking the hormonal profile of oophorectomized individuals and suggesting a new treatment approach.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Five women with endometriosis were given a daily dose of a potent long-acting GnRH agonist, D-Trp6-Pro9-Net-LHRH (GnRH-A) for 28 days in an attempt to suppress ovarian estrogen secretion. The mean level of estradiol (E2) during sampling over 24 hours decreased (P less than 0.01) from 62 +/- 11 to 10 +/- 1 pg/ml at the end of treatment. Mean concentrations of androstenedione, testosterone, estrone and E2 on day 28 of therapy were similar to those measured in oophorectomized women. The level of FSH was decreased (P less than 0.001) during GnRH-a, whereas that of LH was significantly (P less than 0.001) increased, suggesting differing intracellular control mechanisms for release of the two gonadotropins. Desensitization of the pituitary was demonstrated at the end of treatment by a complete lack of acute response of FSH or LH to the daily dose of GnRH-a. "Medical oophorectomy" provides a new approach to the treatment of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (18)
- Biochemical Characterization of Peritoneal Fluid in Women during the Menstrual Cycle* via openalex
- W1974020982 via openalex
- W1980806708 via openalex
- W2033929057 via openalex
- W2035300926 via openalex
- W2037869461 via openalex
- W2040233599 via openalex
- W2047305826 via openalex
- W2067682105 via openalex
- W2083158575 via openalex
- W2116374770 via openalex
- W2135348351 via openalex
- W2139448460 via openalex
- W2160014551 via openalex
- W2161204080 via openalex
- W2169932845 via openalex
- W1503163311 via openalex
- W2336790305 via openalex
Cited by (50)
- Extended GnRH Agonist and NETA Add-Back: An Effective and Safe Option for Refractory Endometriosis/Adenomyosis Pain 2025
- Endometriose Aspectos clínicos do diagnóstico ao tratamento 2021
- Gonadotropin-Releasing Hormone and Its Analogues 2020
- Medikamentozno zdravljenje endometrioze: pregled stanja in nove možnosti zdravljenja 2016
- Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density 2016
- Overview of elagolix for the treatment of endometriosis 2016
- Kuntai Capsule Inhibited Endometriosis via Inducing Apoptosis in a Rat Model 2016
- Pharmacological treatment of endometriosis: review of current and new options for treatment 2016
- Multiple Beneficial Roles of Repressor of Estrogen Receptor Activity (REA) in Suppressing the Progression of Endometriosis 2015
- Estrogen-Induced CCN1 Is Critical for Establishment of Endometriosis-Like Lesions in Mice 2014
- An update on the pharmacological management of endometriosis 2013
- A new isoform of steroid receptor coactivator-1 is crucial for pathogenic progression of endometriosis 2012
- Expression patterns of the steroid receptor coactivator family in human ovarian endometriosis 2011
- Endometriosis: Current and Emerging Therapies 2011
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage and Recombinant Interleukin-2 Left in the Cysts: A Third Clinical Trial 2009
- Las Clínicas de Endometriosis 2009
- Gonadotropin-Releasing Hormone Agonists for Endometriosis 2008
- The Management of Chronic Pelvic Pain 2008
- Tratamento da endometriose 2006
- GnRH-Analoga in der Endometriosetherapie 2006
- Development of an experimental model of endometriosis using mice that ubiquitously express green fluorescent protein 2005
- Treatment of Endometriosis with Transvaginal Ultrasound-Guided Drainage under GnRH Analogues and Recombinant Interleukin-2 Left in the Cysts 2005
- GnRH Analogues, Transvaginal Ultrasound-Guided Drainage and Intracystic Injection of Recombinant Interleukin-2 in the Treatment of Endometriosis 2003
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study 2002
- Medical and Surgical Therapies for Pain Associated with Endometriosis 2001
- BLADDER ENDOMETRIOSIS: 2000
- BLADDER ENDOMETRIOSIS: CONSERVATIVE MANAGEMENT 2000
- Endometriose 2000
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-up 2000
- Combined Medical and Surgical Treatment of Women with Endometriosis 1999
- LH-RH analogues: I. Their impact on reproductive medicine 1999
- The Effect of Gonadotropin-Releasing Hormone Agonist on Type I Collagen C-Telopeptide and N-Telopeptide: the Predictive Value of Biochemical Markers of Bone Turnover 1998
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study 1998
- Comparison between medical treatment by GnRH analogue (goserelin) and conservative surgery by laparoscopic diathermy for the management of endometriosis 1998
- Cost comparisons between nafarelin and leuprolide in the treatment of endometriosis 1998
- Comparison of GnRH Agonist Administration Before and After Laparoscopic Drainage of Endometriomas 1997
- A double-blind randomized study of the treatment of endometriosis with nafarelin or nafarelin plus norethisterone 1997
- Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis 1997
- Goserelin Depot Versus Danazol in the Treatment of Endometriosis The Australian/New Zealand Experience* 1996
- The use of GnRH agonists in the treatment of endometriomas with or without drainage. 1996
- Multiple Polypoid Endometriosis‐A Rare Complication Following Withdrawal of Gonadotrophin Releasing Hormone (GnRH) Agonist for Severe Endometriosis: A Case Report 1996
- Long-acting triptorelin for the treatment of endometriosis 1996
- Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain 1995
- Gonadotropin-releasing hormone agonists 1994
- Multiple gestation following gonadotrophin releasing hormone therapy for the treatment of minimal endometriosis 1994
- Ovarian endometrial cysts: the role of gonadotropin-releasing hormone agonist and/or drainage 1994
- Pretreatment with gonadotrophin releasing hormone (GnRH) analogue prior to in vitro fertilisation for patients with endometriosis 1993
- Buserelin acetate in the treatment of pelvic pain associated with minimal and mild endometriosis: a controlled study 1993
- Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis 1993
- Medical management of endometriosis 1993
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:00.881616+00:00
License: CC0
· commercial use OK